Ensysce Biosciences (ENSC) EBT Margin (2020 - 2025)
Ensysce Biosciences (ENSC) reported EBT Margin of -759.97% for Q3 2025, down 778.71 percentage points from 18.74% a year earlier and down 632.10 percentage points from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) EBT Margin (2020 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Ensysce Biosciences' EBT Margin came in at -246.43%, down 66.99 percentage points year-over-year; for FY2024, it came in at -153.94%, up 342.45 percentage points from FY2023.
- EBT Margin has a four-year change of -269.82 percentage points (FY2020 to FY2024).
- By year, EBT Margin came in at -496.39% in FY2023 (+467.85 pp), -964.25% in FY2022 (-364.85 pp), -599.39% in FY2021 (-715.27 pp) and 115.87% in FY2020.
- The Q3 2025 figure ranks as the lowest quarterly EBT Margin since Q2 2024.
- Year over year, EBT Margin gained in four of the last eight quarters, with an average year-over-year change of +67.46 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2023 (a gain of 2951.07 percentage points); the low point was Q2 2022 (a drop of 3121.16 percentage points).
- Per Business Quant data, the three quarters before Q3 2025 came in at -127.87% (Q2 2025), -149.37% (Q1 2025) and -275.17% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Ensysce Biosciences | 1.02 Mn | -10.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -759.97% |
| Jun 30, 2025 | -127.87% |
| Mar 31, 2025 | -149.37% |
| Dec 31, 2024 | -275.17% |
| Sep 30, 2024 | 18.74% |
| Jun 30, 2024 | -1,090.78% |
| Mar 31, 2024 | -1,011.06% |
| Dec 31, 2023 | -679.66% |
| Sep 30, 2023 | -623.58% |
| Jun 30, 2023 | -467.70% |
| Mar 31, 2023 | -324.55% |
| Dec 31, 2022 | -436.19% |
| Sep 30, 2022 | -2,208.04% |
| Jun 30, 2022 | -3,418.77% |
| Mar 31, 2022 | -798.85% |
| Dec 31, 2021 | -123.48% |
| Sep 30, 2021 | -1,408.33% |
| Jun 30, 2021 | -297.61% |
| Mar 31, 2021 | -707.52% |
| Dec 31, 2020 | -322.05% |
API Access
Ensysce Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();